Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2024

Primary Completion Date

March 26, 2025

Study Completion Date

June 26, 2025

Conditions

Depressive DisorderDepressive Disorder, Treatment-ResistantHallucinogensReinforcement, Psychology

Interventions

DRUG

Psilocybin

Single-dose psilocybin administration: oral ingestion of one 25 mg capsule

OTHER

MRI

1.5 hour brain MRI before and after psilocybin administration

Trial Locations (1)

CHU de Nîmes, Hôpital Universitaire Carémeau, Nîmes

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT06650800 - Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression | Biotech Hunter | Biotech Hunter